(Q41350985)

29 September 2017

title

Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription (English)

1 reference

29 September 2017

Brand T

1

1 reference

29 September 2017

Schneider MD

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

Journal of Biological Chemistry

29 September 2017

published in

1 reference

29 September 2017

volume

270

1 reference

29 September 2017

issue

14

1 reference

29 September 2017

page(s)

8274-8284

1 reference

The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Transforming growth factor-beta in cardiac ontogeny and adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Maternal rescue of transforming growth factor-beta 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

TGF-beta receptors and actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

The types II and III transforming growth factor-beta receptors form homo-oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

TGF beta signals through a heteromeric protein kinase receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Cloning and developmental expression of the chick type II and type III TGF beta receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Characterization of type I receptors for transforming growth factor-beta and activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A transforming growth factor beta type I receptor that signals to activate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Determination of type I receptor specificity by the type II receptors for TGF-beta or activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Inhibition of PDGF β Receptor Signal Transduction by Coexpression of a Truncated Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Cloning of a Second Type of Activin Receptor and Functional Characterization in Xenopus Embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Genomic structure and cloned cDNAs predict that four variants in the kinase domain of serine/threonine kinase receptors arise by alternative splicing and poly(A) addition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Receptor serine/threonine kinases implicated in the control of Drosophila body pattern by decapentaplegic

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A carboxyl-terminal truncated version of the activin receptor mediates activin signals in early Xenopus embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A kinase-negative epidermal growth factor receptor that retains the capacity to stimulate DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Deletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

MyoD or Myf-5 is required for the formation of skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

Inhibition of activin receptor signaling promotes neuralization in Xenopus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.14.8274

21 January 2018

Identifiers

DOI

10.1074/JBC.270.14.8274

1 reference

29 September 2017

1 reference